Estrogen and Antiestrogen Action: Studies in Reproductive Target Tissues and Tumors

  • Benita S. Katzenellenbogen
  • Ten-lin S. Tsai
  • Tochiro Tatee
  • John A. Katzenellenbogen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 117)


Studies are reported using unlabelled and radiolabelled antiestrogens which are aimed at elucidating the nature of interaction of antiestrogens with uterine and mammary tissue. Antiestrogens and long-acting estrogens move estrogen receptor sites to the nucleus and maintain elevated nuclear receptor levels for a prolonged period. The antagonistic action of antiestrogens in the uterus, however, appears to derive from their ability to effect a marked perturbation in the subcellular distribution of receptor whereby very little (ca. 10%) is cytoplasmic and further estrogen receptor accumulation is blocked. In DMBA-induced rat mammary tumors, the nonphototoxic antiestrogen, U-23,469, effectively antagonizes the development and growth of tumors and elicits regression of 90% of established tumors with a time course similar to that seen after ovariectomy. Again, during antiestrogen treatment, the levels of cytoplasmic estrogen receptor are depressed with over 90% of total receptor being found in the nucleus.

Two radiolabelled antiestrogens of high specific activity and purity have been prepared by us and their interaction with nuclear and cytoplasmic estrogen receptors is reported. Both 3H-CI-628 and 3H-U-23,469 are metabolized in vivo to more polar forms which are found associated with the nuclear estrogen receptor, and which may be the true agents active in vivo.


Estrogen Receptor Mammary Tumor Uterine Weight Antiestrogen Action Nuclear Estrogen Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McGuire, W. L., Horwitz, K. B., Zava, D. T., Garola, R. E., and Chamness, G. C. (1978). Metabolism 27: 487–501.PubMedCrossRefGoogle Scholar
  2. 2.
    Katzenellenbogen, B. S. (1978). In “Hormones, Receptors and Breast Cancer” (W. McGuire, ed. ), Raven Press, pp. 135–157.Google Scholar
  3. 3.
    Katzenellenbogen, B. S., and Ferguson, E. R. (1975). Endocrinology 97: 1–12.PubMedCrossRefGoogle Scholar
  4. 4.
    Ferguson, E. R., and Katzenellenbogen, B. S. (1977). Endocrinology 100: 1242–1251.PubMedCrossRefGoogle Scholar
  5. 5.
    Clark, J. H., Anderson, J. N., and Peck, E. J., Jr. (1973). Steroids 22: 707–718.PubMedCrossRefGoogle Scholar
  6. 6.
    Rochefort, H., and Capony, F. (1973). C. R. Acad. Sci. Paris 276: 2321–2325.Google Scholar
  7. 7.
    Lan, N. C., and Katzenellenbogen, B. S. (1976). Endocrinology 98: 220–227.PubMedCrossRefGoogle Scholar
  8. 8.
    Katzenellenbogen, B. S., Ferguson, E. R., and Lan, N. C. (1977). Endocrinology 100: 1252–1259.PubMedCrossRefGoogle Scholar
  9. 9.
    Tsai, T. L., and Katzenellenbogen, B. S. (1977). Cancer Res. 37: 1537–1543.PubMedGoogle Scholar
  10. 10.
    Bloom, H.J.G., and Boesen, E. (1974). Brit. Med. J. 2: 7–10.PubMedCrossRefGoogle Scholar
  11. 11.
    Heuson, J. C., Engelman, E., Blonk-Vander Wijst, J., Maass, H., Drochmans, A., Michel, J., Nowakowski, H. and Gorins, A. (1975). Brit. Med. J. 2: 711–713.PubMedCrossRefGoogle Scholar
  12. 12.
    Kelley, P. A., Asselin, J., Caron, M. G., Labrie, F., and Raynaud, J. P. (1977). J. Nat. Cancer Inst. 58: 623–628.Google Scholar
  13. 13.
    Katzenellenbogen, B. S., and Katzenellenbogen, J. A. (1973). Biochem. Biophys. Res. Commun. 50: 1152–1159.PubMedCrossRefGoogle Scholar
  14. 14.
    Korenman, S. G. (1970). Endocrinology 87: 1119–1123.CrossRefGoogle Scholar
  15. 15.
    Turnell, R. W., Kaiser, N., Millholland, R. J., and Rosen, F. (1974). J. Biol. Chem. 249: 1133–1138.PubMedGoogle Scholar
  16. 16.
    Marver, D., Stewart, J., Funder, J. W., Feldman, D., and Edelman, I. S. (1974). Proc. Nat. Acad. Sci. USA 71: 1431–1435.PubMedCrossRefGoogle Scholar
  17. 17.
    Jordan, V. C., and Prestwich, G. (1977). Molec. Cell. Endocrinol. 8: 179–188.PubMedCrossRefGoogle Scholar
  18. 18.
    Capony, F., and Rochefort, H. (1978). Molec. Cell. Endocrinol. 11: 181–198.PubMedCrossRefGoogle Scholar
  19. 19.
    Sarff, M., and Gorski, J. (1971). Biochemistry 10: 2557.PubMedCrossRefGoogle Scholar
  20. 20.
    Mester, J. and Baulieu, E. E. (1975). Biochem. J. 146: 617–623.PubMedGoogle Scholar
  21. 21.
    Bhakoo, H. S., and Katzenellenbogen, B. S. (1977). Molec. Cell. Endocrinol. 8: 121–134.PubMedCrossRefGoogle Scholar
  22. 22.
    Rochefort, H., and Capony, F. (1977). Biochem. Biophys. Res. Commun. 75: 277–285.PubMedCrossRefGoogle Scholar
  23. 23.
    Sutherland, R., Mester, J., and Baulieu, E. E. (1977). Nature 267: 434–435.PubMedCrossRefGoogle Scholar
  24. 24.
    Ruh, T. S., and Baudendistel, L. J. (1977). Endocrinology 100: 420–426.PubMedCrossRefGoogle Scholar
  25. 25.
    Katzenellenbogen, B. S., Katzenellenbogen, J. A., Ferguson, E. R. and Krauthammer, N. (1978). J. Biol. Chem. 253: 697–707.Google Scholar
  26. 26.
    Clark, J. H., Hardin, J. W., Padykula, H. A., and Cardasis, C. A. (1978). Proc. Nat. Acad. Sci. USA 75: 2781–2785.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1979

Authors and Affiliations

  • Benita S. Katzenellenbogen
    • 1
    • 2
  • Ten-lin S. Tsai
    • 1
    • 2
  • Tochiro Tatee
    • 1
    • 2
  • John A. Katzenellenbogen
    • 1
    • 2
  1. 1.Departments of Physiology & Biophysics and ChemistryUniversity of IllinoisUrbanaUSA
  2. 2.School of Basic Medical SciencesUniversity of Illinois College of MedicineUrbanaUSA

Personalised recommendations